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Atkins  the superior slimming diet?
Abstract
Four diets of varying composition, from the high-protein Atkins diet to the balanced educational tool
LEARN, showedmodest one-year weight-loss resultsbut had no adverse effects. None of the fourdiets reaches
the standard figureof at least 510% used to evaluate the success of weight loss treatments. It seems reasonable
to state that a well-conducted study has shown us that modest weight loss can be achieved in various ways.
However, this is no breakthrough demonstrating that one method is superior to any other, and no reason to
argue that those in favour of high-protein diets were the first to discover the truth of weight loss programs.
F
rom a scientific point of view it is clearly
surprising that diets have repeatedly been
promoted without any proper scientific
ground. The Atkins diet was a huge commercial
success. But the proper scientific evaluation, which
obviously should have been performed by the
inventor of the diet, was not performed until
decades later-and by other scientists. One study
demonstrated that after six months of treatment
of moderately obese but otherwise healthy indivi-
duals weight loss with the Atkins diet was slightly
higher than in a matched control sample. However,
in a parallel study, results after 12 months of
treatment showed no difference.
The ongoing interest in different popular diets
has now led serious scientists to conduct properly
designed prospective randomised and controlled
trials, which of course should have been performed
before any claims were made whatsoever. Gardner
et al. recently published such a well-designed study,
the A TO Z Weight Loss Study, which was
performed on 311 free-living overweight and obese
non-diabetic pre-menopausal women  exactly the
kind of individuals who would particularly look for
such treatment programs. Weight loss after one year
was a primary outcome and secondary outcomes
included the standard metabolic risk factors (1).
The decrease in reported mean energy intake did
not differ between the four groups. Compliance was
surprisingly high with between 76 and 88% partici-
pation at the 12 months final follow-up. After
12 months the weight loss with Atkins was 4.7 kg,
with the Zone diet 1.6 kg, with LEARN 2.6 kg and
with the Ornish diet 2.2 kg. There was a statistically
different weight loss between the Atkins and the
Zone diet but not between the other alternatives.
The metabolic risk factors improved, in principle in
relation to weight loss.
The publication, in one of the most respected
international journals, caused intensive medial ac-
tivity. Journalists published articles demonstrating
that the final word had been said, and clinicians
who had been advocating the high-protein diet
on personal grounds felt that the article had
eventually brought justice to their case. There
seem to be few reasons to argue that a high-protein
diet has adverse effects  a hypothesis that has been
repeatedly forwarded and with particular concern
for subjects with potential renal disease. However,
although the trial is well conducted it is important
not to overstate the outcome and the authors are
careful in their interpretation of the data.
A main shortcoming is that the mean initial body
weight was around 100 kg, which means that the
12 months weight loss even in the Atkins diet was
just about 5%. A standard figure to evaluate success
of any treatment is a weight loss of at least 510%.
But the authors point out another limiting aspect:
For some women weight loss was still continuing,
and it might have been unfair to close the study
after 12 months, when in fact for some individuals
further weight loss could be anticipated.
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